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5-Dimethylaminonaphthalene-l-sulfonyl-Ser-Gln-Asn-Tyr-Pro-Ile-Val-T~ (Dns-SQNYPIVW) is a fluorescent substrate for the aspartyl protease 
of human immunodeficiency virus-l. In intact substrate, fluorescence of Trp (4, 290 nm, &,, 360 nm) was 60% quenched by energy transfer to 
the dansyl group. Protease-catalyzed cleavage at the Tyr-Pro bond abolished the energy transfer, and the consequent increase in Trp fluorescence 
was used to follow the enzymatic reaction. At substrate concentrations < 60 FM, initial reaction velocity increased as a linear function of substrate 
concentration, with k-,/K, = 9700 M-i s-i, Limited solubility and internal fluorescence quenching precluded a determination of KM for Dns- 
SQNYPIVW, but this was clearly > 100 PM. 
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1. INTRODUCTION 
Specific inhibitors of the aspartyl protease of HIV-l’ 
may provide the basis of a new therapy for AIDS [l]. 
The enzyme requires at least a heptapeptide substrate 
[2], and has generally been assayed by HPLC-based 
methods in which the specific hydrolysis of peptide 
substrates is monitored in discontinuous fashion [2]. 
Recently, an absorbance-based spectrophotometric 
method was described which allows the enzyme’s activi- 
ty to be monitored continuously [3]. 
To provide an alternative continuous assay with cer- 
tain advantages, an established strategy for the assay of 
hydrolases [4] was applied to the case of HIV-l pro- 
tease. A peptide substrate of the protease was modified 
by the addition of an energy-transfer pair, giving a 
substrate which allows the enzymatic activity to be 
monitored directly and continuously. In Dns-Ser-Gln- 
Asn-Tyr-Pro-Ile-Val-Trp (Dns-SQNYPIVW), the Dns 
and Trp groups are the N- and C-terminal extensions, 
respectively, of the heptapeptide sequence at the 
p17-p24 cleavage site in the viral gag polyprotein [5]. 
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HIV-l protease cleaves this sequence at the Tyr-Pro 
bond. As Trp and dansyl form an excellent donor-ac- 
ceptor pair for energy-transfer applications 161, the 
Dns-octapeptide can be used for direct fluorescence- 
based assay of the enzyme. 
2. MATERIALS AND METHODS 
2.1. HIV-I protease 
Protease expressed in E. coli MM294 was purified as described [7]. 
Its concentration was determined by amino acid analysis. 
2.2. Peptide synthesis 
Reagents were obtained from Applied Biosystems. Protected 
amino acids used were Boc-Ser(Bzl), Boc-Tyr(BrZ) and Boc- 
Trp(CH0). Ethanolamine and Dns chloride were from Aldrich. 
HPLC was performed on a Waters Delta Prep 3000 with a Vydac C4 
column and a HzO-CHsCN gradient in 0.1% TFA. A Finmgan 45 10 
quadrupole FAB-MS instrument was employed. 
Ser-Gln-Asn-Tyr-Pro-Ile-Val-Trp (0.5 mmol) was assembled on an 
Applied Biosystems Model 430A peptide synthesizer using PAM resin 
and the N-methylpyrrolidone/DMSO program (Ver. 1.40). Final 
acidic deprotection afforded 1.28 g of peptide-resin with a free 
NHr-terminus, of which 280 mg swollen with minimum DCM was 
treated with 5 ml of dry DMF, 0.25 ml of dry triethylamine and 0.4 
g of Dns chloride. The mixture was vortexed overnight in the dark 
(20°C). The peptide-resin was isolated by filtration, washed suc- 
cessively with DMF; DCM; 5% TFA in DCM; DCM; 5% N,N- 
diisopropylethylamine in DCM; and DCM; and dried to afford 290 
mg of peptide-resin in which the peptide was shown by quantitative 
ninhydrin assay [8] to be >99% dansylated. This was vortexed in 10 
ml of 10:7:3:80 HzO:ethanolamine:methanol:DMF for 30 min to 
deformylate the Trp, isolated by filtration and washed in turn with 
DMF, methanol and DCM. Next, the resin-linked peptide was fur- 
ther deprotected using HF containing 10% p-cresol for 1 h (OOC). 
Following removal of the HF, the resin-peptide mixture was taken up 
in minimum TFA, the resin was removed by filtration and the pro- 
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duct peptide isolated by precipitation from diethyl ether (yield; 115 
mg of crude dansylated peptide, 8.5% overall, 78% pure by HPLC 
analysis). The crude peptide (38 mg) was fractionated by HPLC to af- 
ford 7.4 mg of pure Dns-SQNYPIVW after lyophilization in the 
dark. The product gave mass spectral parent ions at masses of 1239 
and 1240 Da, with the ratio of isotopic peak heights equal to 0.7. This 
result identified the product as Dns-SQNYPIVW. 
2.3. HPLC 
HPLC-based assays were performed using a Vydac C-4 column 
(4.6 mm x 15 cm) and a HzO-CHsCN gradient in 0.1% TFA. 
2.4. Fluorimetric enzyme assay 
Dns-SQNYPIVW was dissolved (l-2 mM) in 0.5 M Mes, pH 5.5, 
and its concentration was estimated using ~330 for Dns of 4500 M- 1 
cm -I. ‘Reaction buffer’ was 0.05 M sodium acetate pH 5.5, 13% 
glycerol, 0.01 M D’IT. Fluorescence data were collected using a 
Perkin-Elmer LS-5B luminescence spectrometer interfaced with a 
Macintosh computer. 
3. RESULTS 
3.1. Synthesis of Dns-SQNYPIVW 
Ser-Gln-Asn-Tyr-Pro-Ile-Val-Trp was cr-N-dansyl- 
ated while still coupled to the solid-phase synthesis 
. 
1.0 - 
0.5 - 
resin, selectively deprotected at the formyl-Trp using 
ethanolamine and finally deprotected by HF treatment 
using 10% p-cresol as the sole scavenger (in the dark). 
This strategy emerged from consideration of (i) the 
lability of the glutamine residue [9], (ii) a difficulty with 
migration of the formyl-Trp protecting group observed 
during development of the HF deprotection, and (iii) 
the presence of multiple potential dansylation sites in 
the deprotected peptide. The final preparation of Dns- 
SQNYPIVW contained an impurity eluted just after 
the desired product in HPLC (fig.la) and with mass 1 
Da greater than that of Dns-SQNYPIVW; this was 
identified as a deamidated form of the substrate. 
3.2. Hydrolysis of Dns-SQNYPIVW by HIV-I 
protease 
The sequence -Ser-Gln-Asn-Tyr-Pro-Ile-Val- at the 
p17-p24 junction in the HIV-l gag polyprotein is cleav- 
ed at the Tyr-Pro bond by HIV-l protease [5]. To test 
the enzyme’s ability to accept this sequence flanked by 
Dns and Trp, the cleavage of Dns-SQNYPIVW was 
Fig.1. Action of HIV-l protease on Dns-SQNYPIVW. (a) HPLC of Dns-SQNYPIVW before addition of HIV-l protease (see section 2). (b) 
HPLC analysis of 20 ~1 sample withdrawn from a reaction mixture containing Dns-SQNYPIVW (1.3 x 10e4 M) with HIV-l protease (7 X lo-’ 
M); the sample was diluted by addition to 220 ~1 10% acetic acid and 200 111 was injected. (c) FAB-MS of first-eluted product peak fraction from 
panel b; the predicted M, for Dns-SQNY is 743.7 (note peak at M/Z=744). (d) FAB-MS of second eluted product peak fraction from (b); the 
predicted M, for PIVW is 513.7 (note peak at M/Z=514). 
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analyzed by HPLC (fig.la,b). The two products were 
identified by mass spectrometry (fig.lc,d). The earlier 
eluted product (molecular ion of mass 744) was Dns- 
SQNY (calculated Mr of 743.7) (fig.lc), and the later 
eluted product (molecular ion of mass 514) was PIVW 
(calculated M, of 513.7) (fig.ld). Thus, HIV-l protease 
cleaved Dns-SQNYPIVW at the Tyr-Pro bond. 
3.3. Fluorescence properties of Dns SQNYPIVW 
Addition of HIV-l protease led to time-dependent 
intensity changes in the fluorescence mission spectrum 
of Dns-SQNYPIVW RX 290 nm). The 360 nm Trp 
emission peak progressively increased to - 2.5 times its 
initial intensity while the Dns group’s emission band 
declined in intensity (fig.2a). The data could also be 
viewed as a series of difference spectra (fig.2b). The 487 
nm isosbestic point showed that the proces underlying 
the spectral changes was a conversion involving only 
two states (i.e. substrate + Hz0 to products). 
3.4. Correlation of fluorescence changes with hydro- 
lysis of Dns-SQNYPIVW 
To verify the presumed link between changes in the 
fluorescence of Dns-SQNYPIVW and its hydrolysis, 
the reaction (initially 2.4 ml) shown in fig. 2 was sampl- 
ed between scans (20 ~1 aliquots) for HPLC analysis. 
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Fig.2. Fluorescence mission &,, 290 nm) of Dns-SQNYPIVW and 
its hydrolysis products. See section 2 for conditions. (a) Solid line: 
fluorescence of Dns-SQNYPIVW (3.3 x lo-’ M). Dashed line: the 
same sample following 90 min reaction at 20°C in the presence of 
HIV-l protease (2x lo-* M). (b) Difference spectra from the same 
experiment; the initial spectrum was subtracted from a series of 
spectra recorded at time intervals during the 90 min reaction period. 
The first spectrum was recorded 2 min after the addition of enzyme, 
and subsequent scans were initiated at 6 min intervals thereafter. 
SUBSTRATE (pM) 
Fig.4. Dependence of initial reaction velocity on substrate 
concentration. Assays were performed under the conditions 
described in section 2, using an enzyme concentration of 4.8 x 10e7 
M. Reaction volumes were 0.24 ml. &, was 290 run, and L,,, was 
Arrows show the directions of spectral changes. 360 nm. 
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Fig.3. Progress of fluorescence change at 360 nm (closed symbols) 
and hydrolysis of substrate as measured by HPLC (open symbols). 
The experiment is the same as that shown in fig. 2. 20 ~1 aliquots of 
the reaction (initial volume 2.4 ml) were quenched by addition to 220 
d of ice-cold 10% acetic acid. 
The fluorescence changes and hydrolysis of the 
substrate occurred at the same rate (fig. 3), each follow- 
ing a first-order time course with tl/z of 30 min. 
3.5. Kinetic characterization of proteasecatalyzed 
hydrolysis of Dns-SQNYPIVW 
As the maximum fluorescent change during 
hydrolysis was at 360 nm (fig.2), this wavelength was 
selected for single-wavelength kinetic studies of the 
reaction. Dns-SQNYPIVW was prepared as a stock 
solution of l-2 mM (the limit of its solubility) in 0.5 M 
Mes, pH 5.5, and diluted into reaction buffer for each 
assay; dilution always exceeded 1:20, so that Mes was 
reduced to below 0.025 M. At substrate concentrations 
of l-60 pM, the initial reaction velocity had linear 
dependence on substrate concentration (fig.4). Thus, a 
lower limit of 100 PM could be firmly set upon the KM 
of Dns-SQNYPIVW. With substrate concentrations 
> 100 PM, fluorescence quenching was evident from a 
nonlinear dependence of initial fluorescence on 
substrate concentration. This, and the limited solubility 
of the substrate, precluded exploration of its kinetic 
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behavior at these concentrations. The same difficulties specific chromophoric residue always to be present at 
precluded an estimate of k,,,. From the slope of the line the cleavage site restricts the potential for expIoration 
in fig.4, it was estimated that kc,/& = 9700 M - ’ s - ’ of the enzyme’s pecificity. Current interest in this pro- 
for Dns-SQNYPIVW hydrolysis, consistent with blem [3,12,13] suggests that future studies of HIV-l 
previously reported values for peptides containing the protease and other retroviral proteases wil benefit from 
Tyr-Pro cleavage site [2]. the availability of several optical methods of assay. 
4. DISCUSSION 
The seven-residue sequence between the energy 
donor and energy acceptor groups in Dns-SQNYPIVW 
is unusually long, but may have to be so to satisfy the 
specificity requirements of HIV-l protease [2]. A 
computer-generated model indicates that the dansyl 
and Trp groups are separated by about 2.5 nm if the 
substrate exists in a maximally extended conformation, 
but the 60% fluorescence quenching observed with 
Dns-SQNYPIVW suggests an average separation of 
rather less than 2.0 nm [lO,ll]. Ng and Auld [ll] 
reported near-total quenching in a substrate in which 
Trp and Dns were separated by five residues, noting the 
possible benefit in this respect of including a proline in 
the peptide sequence. Quenching in Dns-SQNYPIVW 
may also be assisted by a proline-dependent conforma- 
tional effect. 
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The method can be refined. Improvements might 
follow from selection of other substrate sequences for 
placement between the energy donor and acceptor 
groups (to give better kinetic properties), addition of 
extra hydrophilic groups to enhance substrate solubili- 
ty, and the exploitation of other fluorophore pairs. 
Placing a range of potential substrate sequences be- 
tween the energy donor and energy acceptor groups will 
allow a fuller and more precise exploration of the en- 
zyme’s specificity. 
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